The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary
Qujia Gama, Shuhan Luo, Pengfei Wu, Lulu Wang, Sijia Liu, Hongwei Zhang, Li Sun, Yiqin Wang, Min Yu, Xiaojun Chen, Weiwei Shan, Xuezhen Luo · 2023
Read The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary by Qujia Gama, Shuhan Luo, Pengfei Wu, Lulu Wang, Sijia Liu, Hongwei Zhang, Li Sun, Yiqin Wang, Min Yu, Xiaojun Chen, Weiwei Shan, Xuezhen Luo (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10704711.txt.
Description
Qujia Gama and co-authors reviewed outcomes for young women who kept their fertility while treated for cancers of both the womb lining and the ovary at once, in a 2023 study. The dual diagnosis is uncommon, and standard care removes the uterus. Their hospital in Shanghai treated eight carefully chosen patients with hormone-based, organ-sparing care between 2016 and 2022.
Half the women had true dual cancers and half had lesser ovarian stages. Seven of eight reached a complete response in a median of under four months, and none relapsed after responding. Four of five women who tried became pregnant and delivered. The authors call the approach feasible for well-selected patients.
Catalog record
| CREATOR | Qujia Gama, Shuhan Luo, Pengfei Wu, Lulu Wang, Sijia Liu, Hongwei Zhang, Li Sun, Yiqin Wang, Min Yu, Xiaojun Chen, Weiwei Shan, Xuezhen Luo |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |